Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the  receptor protein of CRL2Prame complex

Wenjuan Zhang(Fudan University Shanghai Cancer Center), Lijun Jia(Fudan University Shanghai Cancer Center)
Cell Death and Differentiation
January 27, 2021
Cited by 39


Related Papers